Tus kws kho mob
QP84-24 Commercial Pharmacy Benefit Exclusion for Tremfya® and Ocrevus Zunovo™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 591 - 600 ntawm 4179
Tus kws kho mob
QP83-24 MHCP Pharmacy Benefit Exclusion for Tremfya®, Tecentriq Hybreza™ and Ocrevus Zunovo™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
QP82-24 Enhanced Authorization Submissions through Availity Essentials
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
QP80-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
bc-mhcp-pharmprogpolicynotifctn-effective-12-1-24.pdf
Kev Yuav Khoom thiab Kev Kawm Paub
2025 Spanish Individual & Family Dental and Vision Decision Guide
Kev Yuav Khoom thiab Kev Kawm Paub
2025 Spanish Individual & Family Decision Guide
Kev Yuav Khoom thiab Kev Kawm Paub
2025 Spanish Medicare Decision Guide
Guía de Decisiones de Medicare.
Tus kws kho mob
2024 November Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P72-24 Prime Therapeutics Management (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024